Aktive Positionen von Bradford C. Sippy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Direktor/Vorstandsmitglied | 01.07.2016 | - |
| Vorstandsvorsitzender | 01.07.2016 | - | |
| Gründer | 01.07.2016 | - | |
Lennham Pharmaceuticals, Inc.
 Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von Bradford C. Sippy
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
Lennham Pharmaceuticals, Inc.
Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Health Technology |
- Börse
- Insiders
- Bradford C. Sippy
- Erfahrung
